EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 126 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $235,982 | -64.2% | 8,318 | -63.1% | 0.04% | -72.2% |
| Q4 2022 | $659,049 | -47.7% | 22,547 | -52.8% | 0.16% | -44.9% |
| Q3 2022 | $1,261,000 | +481.1% | 47,727 | +876.6% | 0.29% | +394.8% |
| Q2 2022 | $217,000 | -43.8% | 4,887 | -37.3% | 0.06% | -44.2% |
| Q1 2022 | $386,000 | +15.6% | 7,800 | +4.2% | 0.10% | -68.4% |
| Q4 2018 | $334,000 | -3.7% | 7,488 | +49.8% | 0.33% | +39.4% |
| Q3 2018 | $347,000 | +54.2% | 5,000 | +18.5% | 0.24% | +42.2% |
| Q4 2017 | $225,000 | – | 4,218 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |